TRANSCODE THERAPEUTICS, INC. Operating Lease Right-of-Use Assets
TRANSCODE THERAPEUTICS, INC. (RNAZ) had Operating Lease Right-of-Use Assets of $37.73 thousand as of 2024-12-31, per its 10-K filed 2026-04-15.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:OperatingLeaseRightOfUseAsset · last filed 2026-04-15
- 2024-12-31: Operating Lease, Right-of-Use Asset $37.73K.
- 2024-09-30: Operating Lease, Right-of-Use Asset $150.24K.
- 2024-06-30: Operating Lease, Right-of-Use Asset $261.73K.
- 2024-03-31: Operating Lease, Right-of-Use Asset $372.21K.
| Period end | Operating Lease, Right-of-Use Asset |
|---|---|
| 2024-12-31 | $37.73K 10-K · filed 2026-04-15 |
| 2024-09-30 | $150.24K 10-Q · filed 2024-11-14 |
| 2024-06-30 | $261.73K 10-Q · filed 2024-08-14 |
| 2024-03-31 | $372.21K 10-Q · filed 2024-05-15 |
| 2023-12-31 | $481.69K 10-K · filed 2025-04-15 |
| 2023-09-30 | $590.21K 10-Q · filed 2023-11-14 |
| 2023-06-30 | $697.78K 10-Q · filed 2023-08-14 |
| 2023-03-31 | $804.40K 10-Q · filed 2023-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |